Drug Profile
Research programme: pneumococcal conjugate vaccine - Merck/Serum Institute of India
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Merck & Co; Serum Institute of India
- Class Conjugate vaccines; Pneumococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pneumococcal infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Pneumococcal-infections in Unknown (Parenteral)
- 04 Aug 2011 Early research in Pneumococcal infections (Parenteral)